Draft legislation has emerged that ostensibly would boost rapid innovation to combat the coronavirus. Bottom line: The bill is a mixed bag with a lot of questions… The Facilitating Innovation to Fight Coronavirus Act appears to be an attempt to bring any and all viable medical inventions to bear, as quickly as possible, in our fight to defeat COVID-19, which is absolutely to be commended. Despite attempts to mitigate the harm that outright eminent domain on patent rights (vigorously advocated by some) would certainly cause, the legislation needs more work.
Facilitating Innovation to Fight Coronavirus Act— Legislation That’s a Mixed Bag
No Comments
Patent
- Enablement
- Fee Shifting
- Litigation
- Defensive Publications: A Cost-Effective Tool to Supplement Your Patent Strategy
- A Stylized Word Mark in One Country May Be Too Simple and Common in Another
- Other Barks & Bites for Friday, May 22: Copyright Office Issues Section 512 Safe Harbor Report, CAFC Denies Review of PTAB Institution Decision and Director Iancu on Possible Filing Deadline Extension
- CAFC Finds Claim for Delivery Notification System Abstract as Directed to a Longstanding Commercial Practice
- PTAB Institution Data Analysis Proves That Reforms Have Failed
Recent Posts
- Defensive Publications: A Cost-Effective Tool to Supplement Your Patent Strategy
- A Stylized Word Mark in One Country May Be Too Simple and Common in Another
- Other Barks & Bites for Friday, May 22: Copyright Office Issues Section 512 Safe Harbor Report, CAFC Denies Review of PTAB Institution Decision and Director Iancu on Possible Filing Deadline Extension
- CAFC Finds Claim for Delivery Notification System Abstract as Directed to a Longstanding Commercial Practice
- PTAB Institution Data Analysis Proves That Reforms Have Failed